PlainPharmaWatch

CMS Open Payments · Program Year 2024

Pennsylvania

Pennsylvania received $305,383,414.86 in pharmaceutical-industry payments to 31,976 physicians and 72 teaching hospitals across 686,261 transactions.

$305.4M
Total payments
$97.6M
To physicians
$197.7M
To teaching hospitals
#3
of 59 states

In CMS Open Payments Program Year 2024, pharmaceutical and medical-device companies reported $305.4M in payments to 31,976 physicians and 72 teaching hospitals in Pennsylvania. That ranks Pennsylvania #3 of 59 states and territories (2.2% of the US total), averaging $3.1K per physician. Figures are company-reported under the Physician Payments Sunshine Act; a reported payment is a financial relationship, not evidence of wrongdoing.

The verdict

Pennsylvania pairs top-5% payment volume with a hospital-heavy payment mix.

#3
of 59 states
2.2%
of the national total
32.0%
to physicians vs. hospitals
31,976
physicians paid

What the Data Shows for Pennsylvania

Pennsylvania's Open Payments file is hospital-weighted: 64.7% of $305.4M went to 72 teaching hospitals ($2.7M each), with 32.0% on 31,976 physicians.

On the national dollar ranking it is still #3 of 59 (2.2% of US payments). Average transaction $445.00. Leading nature of payment: "Royalty or License" at $200.3M (65.6% of the state file; top-three natures 84.7%).

Pennsylvania sits in the 97th percentile (top-10 nationally). Just above: Florida ($334.6M). Just below: Massachusetts ($230.3M). For context: top-ranked California ($342.4M) is 1.1× larger than Pennsylvania. CMS Sunshine Act framework and methodology.

Physician vs Hospital Payments

How pharmaceutical payments in Pennsylvania are distributed between physicians and teaching hospitals.

Physician Payments

$97.6M

32.0% of total · 31,976 recipients · $3.1K avg

Teaching Hospital Payments

$197.7M

64.7% of total · 72 hospitals · $2.7M avg

Payment Breakdown by Type

Pennsylvania has 16 types of pharmaceutical payments. "Royalty or License" accounts for 65.6%.

Nature concentration in Pennsylvania

Top three Open Payments natures are 84.7% of state dollars; residual is every other reported nature

Royalty or License$200.3MCompensation for Services Ot…$30.2MConsulting Fee$28.2MAll other natures (13)$46.7M

Payment categories in Pennsylvania

Top categories by total reported dollar volume

1. Royalty or License$200.3M2. Compensation for Services…$30.2M3. Consulting Fee$28.2M4. Food and Beverage$17.5M5. Travel and Lodging$9.3M6. Grant$5.8M7. Education$3.9M8. Honoraria$2.9M9. Long-Term Medical Supply …$2.5M10. Space Rental or Facility…$1.8M
Payment Type Amount Transactions
Royalty or License $200.3M 758
Compensation for Services Other Than Consulting $30.2M 11,295
Consulting Fee $28.2M 9,488
Food and Beverage $17.5M 625,769
Travel and Lodging $9.3M 27,772
Grant $5.8M 398
Education $3.9M 6,321
Honoraria $2.9M 1,031
Long-Term Medical Supply or Device Loan $2.5M 658
Space Rental or Facility Fees $1.8M 456
Compensation for Faculty or Speaker (Medical Education) $1.5M 767
Debt Forgiveness $884.5K 189
Charitable Contribution $282.6K 86
Acquisitions $189.4K 16
Gift $151.9K 1,085
Entertainment $21.4K 172

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Source: CMS Open Payments Database Industry payments to physicians and teaching hospitals · 2024

What Pennsylvania totals can and cannot tell you

The aggregate payment figure for Pennsylvania measures reportable industry–physician engagement inside this state's geographic footprint for Program Year 2024, not any one physician's or hospital's relationship with industry. CMS collects the data under the Physician Payments Sunshine Act; manufacturers must report transfers of value above the de minimis threshold. The file does not capture DTC advertising, internal R&D, wholesale drug pricing, or salary support that is not a reportable transfer of value.

Correlations between payment receipt and prescribing appear in peer-reviewed work for specific drugs and specialties, but this page's state total does not establish causation. Open the company and recipient detail pages for category and year-over-year cuts.

View saved (states)
Download Pennsylvania's data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.